Drugs / dyhydroprogestrone
last change Apr 2007 re-read 2 minutes ago

dyhydroprogestrone

Developed for
schizophrenia
Investigated by
Stanley Medical Research Institute · The Alfred

Trials 1 · a red edge is where a trial was stopped

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00206557 Oct 2002 → Apr 2007 schizoaffective disorder, schizophrenia, schizophreniform disorder The Alfred Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as dyhydroprogestrone ClinicalTrials.gov intervention name — accepted as the source's own label NCT00206557
Route Oral “dyhydroprogesterone 10mg oral per day” NCT00206557